Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide for Transfusion-Dependent Beta-Thalassemia Hb E
TCTR20251222013Phase 3Not yet recruiting
- Sponsor
- Thai Society of Hematology
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of thalidomide in beta thalassemia, sponsored by Thai Society of Hematology. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
thalidomide
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on TCTR20251222013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251222013.